| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Gengos Andrew | Chief Financial Officer | C/O TERNS PHARMACEUTICALS, INC., 1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY | /s/ David Strauss, as Attorney-in-Fact for Andrew Gengos | 16 Jun 2025 | 0001563623 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TERN | Common Stock | Purchase | $18,750 | +5,000 | $3.75 | 5,000 | 13 Jun 2025 | Direct | ||
| transaction | TERN | Common Stock | Purchase | $18,600 | +5,000 | +100% | $3.72 | 10,000 | 13 Jun 2025 | Direct | |
| transaction | TERN | Common Stock | Purchase | $19,732 | +5,000 | +50% | $3.95 | 15,000 | 16 Jun 2025 | Direct |